T. Dorman et al., RADIAL ARTERY PRESSURE MONITORING UNDERESTIMATES CENTRAL ARTERIAL-PRESSURE DURING VASOPRESSOR THERAPY IN CRITICALLY ILL SURGICAL PATIENTS, Critical care medicine, 26(10), 1998, pp. 1646-1649
Objectives: Radial artery pressure is known to differ from central art
erial pressure in normal patients (distal pulse amplification) and in
the early postcardiopulmonary bypass period. The adequacy of the radia
l artery as a site for blood pressure monitoring in critically ill pat
ients receiving high dose vasopressors has not been carefully examined
. Design: Prospective observational study comparing simultaneous intra
arterial measurements of radial (peripheral) and femoral artery (cent
ral) pressures. Setting: Clinical investigation in a university based
surgical intensive care unit. Patients: Fourteen critically ill patien
ts with presumed sepsis who received norepinephrine infusions at a rat
e of greater than or equal to 5 mu g/min. Interventions: All patients
were managed in accordance with our standard practice for presumed sep
sis, which consisted of intravascular volume repletion followed by vas
opressor administration titrated to a mean arterial pressure of greate
r than or equal to 60 mm Hg. Measurements and Main Results: Systolic a
nd mean arterial pressures were significantly higher when measured fro
m the femoral vs, radial site (p <.005). The higher mean arterial pres
sures enabled an immediate reduction in norepinephrine infusions in 11
of the 14 patients. No change in cardiac output or pulmonary artery o
cclusion pressure was noted after dose reduction. In the two patients
in whom simultaneous recordings were made after discontinuation of nor
epinephrine infusions, equalization of mean arterial pressures was obs
erved. Conclusions: Radial artery pressure underestimates central pres
sure in hypotensive septic patients receiving high dose vaso presser t
herapy. Clinical management, based on radial pressures, may lead to ex
cessive vasopressor administration. Awareness of this phenomena may he
lp minimize adverse effects of these potent agents by enabling dosage
reduction.